Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.verified

QLGN

Price:

$3.21

Market Cap:

$13.57M

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in...[Read more]

Industry

Biotechnology

IPO Date

2015-06-23

Stock Exchange

NASDAQ

Ticker

QLGN

The ROE as of November 2025 (TTM) for Qualigen Therapeutics, Inc. (QLGN) is -72.97%

According to Qualigen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -72.97%. This represents a change of -96.32% compared to the average of -1980.38% of the last 4 quarters.

Qualigen Therapeutics, Inc. (QLGN) Historical ROE (quarterly & annually)

How has QLGN ROE performed in the past?

The mean historical ROE of Qualigen Therapeutics, Inc. over the last ten years is -14.62%. The current -72.97% ROE has changed 399.27% with respect to the historical average. Over the past ten years (40 quarters), QLGN's ROE was at its highest in in the December 2023 quarter at 116.48%. The ROE was at its lowest in in the March 2025 quarter at -7986.27%.

Quarterly (TTM)
Annual

Average

-14.62%

Median

-111.61%

Minimum

-257.62%

Maximum

637.83%

Qualigen Therapeutics, Inc. (QLGN) ROE by Quarter and Year

Discovering the peaks and valleys of Qualigen Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 138.44%

Maximum Annual ROE = 637.83%

Minimum Annual Increase = -347.59%

Minimum Annual ROE = -257.62%

Quarterly (TTM)
Annual
YearROEChange
2024-233.64%-136.63%
2023637.83%-347.59%
2022-257.62%138.44%
2021-108.04%-3.20%

Qualigen Therapeutics, Inc. (QLGN) Average ROE

How has QLGN ROE performed in the past?

The current ROE of Qualigen Therapeutics, Inc. (QLGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

48.86%

5-year avg

-14.62%

10-year avg

-14.62%

Qualigen Therapeutics, Inc. (QLGN) ROE vs. Peers

How is QLGN’s ROE compared to its peers?

Qualigen Therapeutics, Inc.’s ROE is greater than Soligenix, Inc. (-274.80%), greater than Oragenics, Inc. (-4705.41%), greater than Titan Pharmaceuticals, Inc. (-108.55%), greater than Can-Fite BioPharma Ltd. (-182.93%), greater than Xenetic Biosciences, Inc. (-64.62%), less than Kazia Therapeutics Limited (335.37%), greater than Ensysce Biosciences, Inc. (-386.70%), greater than CNS Pharmaceuticals, Inc. (-130.12%), greater than Clearmind Medicine Inc. (-164.77%), greater than KALA BIO, Inc. (-2323.94%),

Build a custom stock screener for Qualigen Therapeutics, Inc. (QLGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qualigen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Qualigen Therapeutics, Inc. (QLGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Qualigen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Qualigen Therapeutics, Inc.'s ROE?

How is the ROE calculated for Qualigen Therapeutics, Inc. (QLGN)?

What is the highest ROE for Qualigen Therapeutics, Inc. (QLGN)?

What is the 3-year average ROE for Qualigen Therapeutics, Inc. (QLGN)?

What is the 5-year average ROE for Qualigen Therapeutics, Inc. (QLGN)?

How does the current ROE for Qualigen Therapeutics, Inc. (QLGN) compare to its historical average?